Goodwin advised TCR2 Therapeutics on the completion of its highly oversubscribed $125 million Series B financing round. Proceeds of the financing will be used to advance…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now